Methylprednisolone in acute spinal cord injuries

Irish Journal of Medical Science

Volumn 172, Issue 1, 2003, Pages 24-26

  O'Connor, P A ^a   McCormack, O ^a   Gavin, C ^a   Dungan, R ^b   Kirke, C ^b   McCormack, D ^a   O'Byrne, J ^a   Stephens, M ^a   McManus, F ^a   Walsh, M ^a,b  

^a Stillorgan Co   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; BOLUS INJECTION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG INFUSION; DRUG MEGADOSE; DRUG USE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HUMAN; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL AUDIT; MEDICAL DOCUMENTATION; MEDICAL RECORD; NERVOUS SYSTEM INJURY; NEUROPROTECTION; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT TRANSPORT; PRACTICE GUIDELINE; PRESCRIPTION; RETROSPECTIVE STUDY; SPINAL CORD INJURY; TIME; TREATMENT OUTCOME;

EID: 0038813917     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02914781     Document Type: Article

References (13)

1. Bracken MB, Collins WF, Freeman DF. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984; 251: 45-52.
2. Bracken MB, Shepard MJ, Collins WF et al. A randomised controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N Engl J Med 1990; 322: 1405-11.
3. Bracken MB, Shepard MJ, Holford TR et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. JAMA 1997; 277: 1597-604.
4. Callanan I, Walsh M. Management of spinal injuries. Poster. 1998. Available form the National Spinal Injuries Unit, Mater Misericordiae Hospital, Dublin.
5. Coleman WP, Benzel D, Cahill DW et al. A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury. J Spinal Disord 2000; 13: 185-99.
6. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000; 93: 1-7
7. Geisler FH, Coleman WP, Grieco G et al. The Sygen® multicentre acute spinal injury study. Spine 2001; 26 (suppl 1): S87-98.
8. Fehlings MG, Bracken MG. Summary statement: The Sygen® (GM-1 Ganglioside) clinical trial in acute spinal cord injury. Spine 2001; 26 (suppl 1): S99-100.
9. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high dose methylprednisolone sodium succinate treatment in the follow up of acute cervical spinal cord injury. Spine 2001; 26: 426-30.
10. Bracken MB, Shepard MJ, Hellenbrand KG et al. Methylprednisolone and neurological function one year after spinal cord injury. J Neurosurg 1985; 63: 704-13.
11. Goldfien A. Adrenocorticosteroids and adrenocortical antagonists. In: Basic and clinical pharmacology (3rd Edition). Ed Katzung BG. Appleton and Lange, CA 1987: 453.
12. Fehlings MG. Editorial: Recommendations regarding the use of methylprednisolone in acute spinal cord injury. Spine 2001; 26 (suppl 1): S56-57.
13. Delamarter RB, Coyle J. Acute management of spinal cord injuries. J Am Acad Ortho Surg 1999; 7: 166-75.